Elevated levels of serum fatty acid synthase in patients with gastric carcinoma

Gastric cancer is the second leading cause of cancer mortality in the world. It is important to develop biomarkers for detecting new cancers at an early stage and for treating them early during recurrence in order to guide optimal treatment. Fatty acid synthase (FAS) is highly expressed in numerous...

Descripción completa

Detalles Bibliográficos
Autores principales: ITO, TOMOAKI, SATO, KOICHI, MAEKAWA, HIROSHI, SAKURADA, MUTSUMI, ORITA, HAJIME, SHIMADA, KAZUNORI, DAIDA, HIROYUKI, WADA, RYO, ABE, MASAAKI, HINO, OKIO, KAJIYAMA, YOSHIAKI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919915/
https://www.ncbi.nlm.nih.gov/pubmed/24527066
http://dx.doi.org/10.3892/ol.2014.1793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919915/
https://www.ncbi.nlm.nih.gov/pubmed/24527066
http://dx.doi.org/10.3892/ol.2014.1793

Ejemplares similares